Back

Anti-arrhythmic drug use signals higher recurrence risk of accessory pathways after ablation

10 May 2026 (15:30 - 16:30)
Organised by: Logo
Congress Presentation Part of: ePosters in atrial fibrillation (1) Clinical HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Miguel Rocha

Sao Joao University Hospital Centre, Porto (Portugal)

7 More presentations in this session

Presentation thumbnail
Factors associated with one-year maintenance of sinus rhythm after successful electrical cardioversion of persistent atrial arrhythmias in patients with cardiac implantable electronic devices
Doctor K. Zivic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Left bundle branch area pacing: baseline characteristics and echocardiographic response: trends in patients with atrial fibrillation
Doctor A. Phelan (Dublin 9, IE)
Abstract Slides
Presentation thumbnail
Impact of symptomatic status on atrial fibrillation recurrence after pulmonary vein isolation
Doctor A. Castro Pinto (Guimaraes, PT)
Abstract Slides
Presentation thumbnail
Early arrhythmia recurrence as a determinant of long-term rhythm outcomes after atrial fibrillation and flutter ablation
Doctor F. Lemos De Sousa (Vila Nova de Gaia, PT)
Abstract Slides
Presentation thumbnail
Prevalence of arrhythmias and device therapy in hospitalized patients with HFpEF: a single-center retrospective cohort
Ms D. Anutoni (Timisoara, RO)
Abstract Slides

Access the full session

Session thumbnail
ePosters in atrial fibrillation (1)

The Event

Event poster

Heart Failure 2026

10 May 2026 15:30 CET
You may be interested in
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources